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ABSTRACT
Neural crest cells migrate long distances throughout the embryo and
rely on extracellular signals that attract, repel and/or stimulate survival
to ensure proper contribution to target derivatives. Here, we show that
leukocyte receptor tyrosine kinase (LTK), an ALK-type receptor tyrosine
kinase, is expressed by neural crest cells during early migratory stages
in chicken embryos. Loss of LTK in the cranial neural crest impairs
migration and results in increased levels of apoptosis. Conversely,
midkine, previously proposed as a ligand for ALK, is secreted by the
non-neural ectoderm during early neural crest migratory stages and
internalized by neural crest cells in vivo. Similar to loss of LTK, loss of
midkine reduces survival of the migratory neural crest. Moreover, we
show by proximity ligation and co-immunoprecipitation assays that
midkine binds to LTK. Taken together, these results suggest that LTK in
neural crest cells interacts with midkine emanating from the non-neural
ectoderm to promote cell survival, revealing a new signaling pathway
that is essential for neural crest development.
KEY WORDS: Neural crest, LTK, Midkine, Cell survival, Apoptosis,
Chicken
INTRODUCTION
The neural crest is a population of stem-like cells that emigrates from
the dorsal neural tube and forms a vast array of derivatives in the
vertebrate embryo. Neural crest cells not only contribute to the
peripheral nervous system, but also to the craniofacial skeleton,
parts of the cardiac outflow tract and all skin pigment cells (Green
et al., 2015; Le Douarin and Kalcheim, 1999). Onset of neural crest
migration begins with an epithelial-mesenchymal transition (EMT)
that resembles the first steps of cancer metastasis: attachment
between epithelial cells is lost and emigration proceeds with
invasion of the basal extracellular matrix (Acloque et al., 2009;
Kerosuo and Bronner-Fraser, 2012; Thiery et al., 2009).
Changes in cell shape and adhesive properties that occur during
EMT enable detachment of neural crest cells and their subsequent
migration through mesenchymal tissue (Rogers et al., 2013;
Scarpa et al., 2015). A number of extracellular signals have been
identified that interact with receptors present in the membrane of
migrating neural crest cells to regulate their direction of migration,
proliferation and survival; these include ErbB/neuregulin,
Eph/Ephrin, neuropilin/semaphorin, CXCR4/SDF and VEGFR/
VEGF (Kulesa and Gammill, 2010; Gammill et al., 2007;
McLennan et al., 2010; Olesnicky Killian et al., 2009; Osborne
et al., 2005; Schwarz et al., 2008; Theveneau et al., 2010;
Theveneau and Mayor, 2012). In addition, cell adhesion
molecules are crucial for many aspects of EMT and progression
of cell migration. For example, EMT is accompanied by a switch
in expression from type 1 (Ecad and Ncad) to type 2 (Cad7, Cad6b
and Cad11) cadherins (Cheung et al., 2005; Dottori et al., 2001;
Fairchild and Gammill, 2013; Kashef et al., 2009; Nieto et al.,
1994; Taneyhill et al., 2007; Taneyhill, 2008; Vallin et al., 1998).
In addition, Cad6B must be repressed for dissociation of neural
crest cells from the neural tube (Coles et al., 2007) and Ecad is
important for neural crest cell-cell adhesion during early migration
in both chick and frog (Huang et al., 2016; Rogers et al., 2013).
Some differences, however, exist between species: whereas
maintenance of Ncad is important for contact inhibition of
locomotion during migration in Xenopus and zebrafish (Bahm
et al., 2017; Scarpa et al., 2015; Theveneau et al., 2010), Ncad is
absent from migrating neural crest cells in chick, which instead
express cadherin 7 (Rogers et al., 2018).
In an effort to identify novel signaling and adhesion molecules
that may play a role during neural crest migration, we have
performed transcriptional profiling of early migrating cranial neural
crest cells (Simões-Costa et al., 2014). Among the genes uncovered,
leukocyte receptor tyrosine kinase (LTK) was found to have a
striking neural crest-specific expression pattern. LTK was first
identified in cells of hematopoietic origin and later found to be
required for proliferation and survival of iridophores in zebrafish
embryos (Ben-Neriah and Bauskin, 1988; Fadeev et al., 2016;
Lopes et al., 2008). However, the endogenous function of LTK
during cell migration has been unclear. In chicken, LTK is more
similar in structure to its better-known vertebrate paralog anaplastic
lymphoma kinase (ALK), mutations of which result in pediatric
neural crest-derived tumors of the sympathoadrenal lineage, the cell
type in which ALK is first expressed (Hurley et al., 2006). The
conserved extracellular region of ALK/LTK contains a low-density
receptor class A repeat (LDLa) flanked by one or two meprim/A5
protein/PTPµ (MAM) domains and a glycine-rich region (GlyR), the
conservation of the latter also extending to mammals. LTK and ALK
were considered orphan receptors until the recent discovery that
secreted proteins previously known as FAM150A/B bind to the GlyR
domain (Guan et al., 2015; Reshetnyak et al., 2015; Zhang et al.,
2014). As a result, these proteins were renamed as ALK and LTK
ligand-1/2 (ALKAL1 and ALKAL2). Recently, both were shown to
be required for formation of zebrafish iridophores, a process
dependent on LTK activity (Lopes et al., 2008; Fadeev et al., 2016;
Mo et al., 2017). However, the presence of other conserved domains
in the extracellular region suggests that the full range of LTK and
ALK ligands remains ill-defined. For example, it has been suggested
that the heparin-binding cytokines midkine and pleiotrophin are
ligands for ALK (Stoica et al., 2001, 2002), and midkine affects
proliferation of sympathetic neurons in a manner thought to be ALK
dependent (Reiff et al., 2011).Received 6 February 2018; Accepted 13 September 2018
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Here, we reveal a functional interaction between LTK and
midkine during early neural crest migration. We find that chicken
LTK is required for survival of migrating cranial neural crest cells,
but not for neural crest identity. During early migration, cranial crest
cells expressing LTK are in contact with the basal lamina of the non-
neural ectoderm before moving ventrally. Our data show that
midkine produced by the non-neural ectoderm accumulates in the
basal lamina, binds to LTK and is internalized by neural crest cells,
which require midkine for survival. This anti-apoptotic effect of
LTK/midkine provides evidence for a new signaling pathway that is
important for neural crest development.
RESULTS
LTK is expressed in migrating neural crest cells
As a first step in addressing the role of LTK during neural crest
development, we examined its expression pattern at different
embryonic stages. To this end, we performed whole-mount in situ
hybridization on chicken embryos between Hamburger and
Hamilton (HH) stages 4 and 19 (Hamburger and Hamilton,
1951). At HH4-5, corresponding to gastrula stages, LTK
transcripts were solely detected in cells adjacent to the primitive
streak, likely to be ingressing mesodermal cells (Fig. S1A,B).
Expression in the neural crest was first observed in the dorsal
neural folds of stage HH8+ embryos (Fig. 1A). By stage HH10,
strong LTK signal was present in migrating cranial neural crest
cells that co-expressed the HNK-1 antigen, as well as in pre-
migratory cardiac/vagal neural crest cells (Fig. 1B-D). At stage
HH14, LTK expression was already present in premigratory trunk
neural crest cells and maintained during their migration at HH19
(Fig. 1E,F). At this later stage, LTK expression was detected in the
trigeminal ganglia and in vagal and trunk neural crest migration
streams (Fig. 1F,G).
Loss of LTK impairs cranial neural crest migration
To determine whether LTK is required in migrating neural crest
cells, we performed loss-of-function experiments with a fluorescein
(FITC)-tagged antisense splice-blocking morpholino oligo (MO)
targeting the LTK exon 8/intron 8 junction by ex ovo electroporation
of the ectoderm of late gastrula stage embryos (HH6). To confirm
activity of the MO, we electroporated embryos with morpholinos
and harvested RNA from stage HH8+ dorsal neural folds to analyze
the splicing of the target region with RT-PCR. Sequencing of the
products obtained revealed that LTK-targeted MO (LTK-MO)
caused skipping of exon 8 and a reading frame shift, producing a
premature stop codon that truncates translation of LTK at the MAM
domain, whereas a FITC-tagged standard control morpholino (ctrl-
MO) did not perturb splicing of LTK (Fig. S2A).
To study the effects of MO-mediated knockdown in migrating
neural crest cells, we electroporated HH6 embryos with LTK-MO
on the right side and ctrl-MO on the left side, thus providing
an internal control. Embryos were incubated to stage HH9+
(8-9 somites), corresponding to the time when the cranial neural
crest had just started emigrating from the neural tube, then fixed and
immunostained for the neural crest transcription factor Pax7
(Fig. 2A). To assess the average distance migrated away from the
neural tube, we measured the area occupied by the right-side and
left-side migrating populations. The data show that neural crest
populations transfected with LTK-MO spread across an area
equivalent to, on average, 85.7% of controls (Fig. 2B-D,H).
To confirm the MO phenotype using a second approach, we used
CRISPR/Cas9 plasmid constructs, previously optimized for
electroporation of chicken embryos, to induce mutations in the
LTK locus (Gandhi et al., 2017). For this purpose, we designed a
guide RNA (gRNA) targeting exon 20 of LTK (LTK.20), with the
goal of specifically disrupting translation of the intracellular kinase
Fig. 1. LTK is expressed in migrating neural crest cells. (A) In situ hybridization showing LTK expression at stage HH8 in the dorsal neural folds (arrow)
containing premigratory neural crest cells prior to neural tube closure. (B-D) At stage HH10, LTK transcripts are detected in migrating cranial neural crest
cells (B, arrow) and overlapped with HNK-1 immunostaining in transverse sections (C,D, arrowheads), confirming their identity. (C,D) Transverse section
of the region indicated by the dashed line in B. (E) At stage HH14, LTK expression is observed in later migrating cranial neural crest cells and in migrating
and pre-migratory cardiac/vagal and trunk neural crest cells (arrows). (F) At stage HH19, LTK expression continues in migrating neural crest cells, trigeminal
ganglia (arrow) and in cells located in the heart. (G) Transverse section of the region indicated by the dashed line in F, showing strong signal in dorsal root
ganglia (arrow). CNC, cranial neural crest; DRG, dorsal root ganglia; NF, neural folds; TG, trigeminal ganglia; TNC, trunk neural crest; VCNC, vagal/cardiac neural
crest. Scale bars: 200 µm in A,B,E; 20 µm in C,D; 500 µm in F; 100 µm in G.
2
RESEARCH ARTICLE Development (2018) 145, dev164046. doi:10.1242/dev.164046
D
E
V
E
LO
P
M
E
N
T
domain at the carboxyl terminus without affecting membrane
localization. To validate efficiency of this gRNA, we transfected a
line of DF-1 chicken embryonic fibroblasts that constitutively
expresses Cas9 (Gandhi et al., 2017) with LTK.20 driven by a
chicken U6 promoter (cU6.3) and extracted genomic DNA after
48 h for PCR amplification followed by cloning and sequencing of
the target region. Analysis of the data confirmed at least one deletion
event on the target site that led to frameshift with a premature stop
codon, validating the gRNA activity (Fig. S2B). This was a large
deletion of 774 bp, suggesting that other CRISPR/Cas9-induced
lesions at the LTK locus may not be readily accessible by routine
detection methods (Kosicki et al., 2018). To knock down LTK in the
neural crest, we electroporated CAG promoter-driven Cas9 and
cU6.3-driven LTK.20 into the right side of HH4-5 embryos,
together with pCI-H2B-RFP (Betancur et al., 2010) as a reporter. At
the same time, a standard control gRNAwas used in the left side as
an internal control. Following transfection, the embryos were
incubated until stage HH9+, then fixed and immunostained for
Pax7. Analysis of the area occupied again indicated that LTK was
required in migrating neural crest cells. On average, the populations
transfected with LTK.20 occupied an area equivalent to 88.2% of
contralateral control populations (Fig. 2E-H). Further supporting
an LTK requirement, similar defects were observed after injection
of the ALK/LTK pharmacological inhibitors ceritinib and
crizotinib (Rodrigues et al., 2012) into the head mesenchyme of
stage HH9 embryos (Fig. S3A-C), and after electroporation of
pCI-H2B-RFP(V5-LTK-ΔICD), encoding an amino-terminal
V5-tagged putative dominant-negative version of LTK that lacks
the intracellular domain (LTK-ΔICD; Fig. S3D,E), designed in a
similar fashion to previously described RTK dominant-negatives
(Amaya et al., 1991; Saffell et al., 1997; Ueno et al., 1995).
To test whether loss of LTK alters neural crest specification, we
performed immunostaining for Pax7 in MO-treated HH8 embryos,
prior to neural tube closure and onset of migration, and observed no
reduction in the neural crest population (Fig. 3A,B) or increased
cell death (Fig. 3C), also excluding MO toxicity as a cause for
the phenotype observed. We also stained HH10 embryos after MO-
or CRISPR/Cas9-induced loss of LTK for neural crest markers
FoxD3, Ets1, Sox10, Snail2 and Sox9, and found no obvious
difference in their levels (Fig. 3D-H), suggesting that neural crest
identity is not downstream of LTK. These markers, however,
showed migration defects similar to Pax7 (Fig. 2H), where LTK-
depleted Snail2+ and Sox9+ cells occupied on average an area
equivalent of 89.7% and 80.3% of controls, respectively (Fig. 3I).
We also observed no obvious effects in the expression of adhesion
and extracellular matrix molecules associated with EMT, such as
E-cadherin (Ecad), cadherin-6B (Cad6B) and laminin (Fig. S4).
However, a reduction in the expression of the late migration marker
HNK-1 suggested loss of neural crest cells during early migration
(Fig. 3J).
LTK is required for survival of migrating neural crest cells
The results obtained with loss-of-function experiments might be
due to defective cell migration and/or loss of neural crest cells.
Fig. 2. Loss of LTK impairs cranial neural crest migration. (A) Diagram showing bilateral ectoderm electroporation of gastrula-stage chicken embryos
with control reagents on the left side and LTK-targeted reagents on the right side, followed by ex ovo culture until stage HH9+. At this stage, dorsal view imaging
of the neural crest allows area measurements suitable for comparing the average distance migrated. EP, electroporation; IF, immunofluorescence.
(B) Immunostaining for Pax7 after MO-mediated unilateral depletion of LTK showing reduced migration on the right side. (C,D) Pax7 immunostaining (C) and MO
FITC-tag signal (D) in a transverse section of the embryo shown in B. (E) Immunostaining for Pax7 after CRISPR/Cas9-mediated unilateral depletion of LTK
showing reduced migration on the right side. (F,G) Pax7 immunostaining (F) and RFP signal (G) in a transverse section of the embryo shown in E. RFP
reporter and Cas9 were electroporated on both sides (G). (H) Quantification of the Pax7 field areas in experimental and contralateral control sides showing
significant decrease in the area spread by LTK-depleted neural crest, on average to 85.5% after MO treatment (n=18, P=0.0001) and 88.2% (n=28, P<0.0001)
after CRISPR/Cas9 treatment. No significant difference (NS) was observed between the sides of wild-type (WT) embryos. The data are normalized to the
left side average of each group and a two-tailed paired t-test was used to calculate statistical significance of the difference between left and right sides.
Mean±s.e.m values are plotted as black bars. In this and subsequent figures, dotted line indicates midline. Scale bars: 50 µm.
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Besides the clear and reproducible reduction in the area occupied
by neural crest cells, we also noted in transverse sections an
apparent reduction in the number of migrating neural crest cells
(Fig. 2E,G and Fig. 4A-D). To test whether this was correct, we
counted the number of Sox9+ cells after CRISPR-mediated loss of
LTK. The results showed that depletion of LTK caused on average a
reduction to 65.3% in the number of Sox9+ cells compared with
contralateral controls (Fig. 4E). Because onset of LTK expression
takes place after neural crest specification and our results show that
neither neural crest identity nor EMT were altered by its loss, this
suggested that LTK function is important for ensuring proper size of
the neural crest cell population, possibly by promoting cell survival.
To test this possibility, we performed immunostaining for cleaved
caspase 3, a marker for apoptotic cells. The results did indeed show
increased levels of caspase 3-mediated apoptosis of early migrating
neural crest cells transfected with CRISPR/Cas9 plasmids (Fig. 4F-J).
These results confirmed that the phenotype observed was at least in
part caused by increased cell death during migration. Increased
signal for cleaved caspase 3 in the Pax7+ migratory population after
electroporation of LTK-ΔICD further supported these findings
(Fig. S3E-G). Although we could not completely rule out an effect
on cell migration as well, we found that LTK-depleted neural crest
explants produced cells that migrated distances similar to cells from
control explants (Fig. S5A,B,D,E), but also with higher levels of
caspase 3-mediated apoptosis (Fig. S5C,F). Altogether, these data
indicated that the main function of LTK is promoting cell survival
during migration.
Midkine is expressed in the non-neural ectoderm juxtaposed
to migrating neural crest cells
When screening full-length clones of chicken LTK obtained from
stage HH10 cDNA, we identified two predominant variants.
Interestingly, one of the isoforms lacked exon 16 and much of the
glycine-rich region (GlyR) responsible for binding ALKAL1/2 in
mammals and fish (Fig. S6) (Fadeev et al., 2018; Guan et al., 2015;
Mo et al., 2017; Reshetnyak et al., 2015; Zhang et al., 2014). This
raised the intriguing possibility that ligands other than ALKAL1/2
may bind to LTK during early neural crest migration. Moreover, a
sequence homologous to ALKAL1 in the chicken genome appears to
have lost its function as there are no recognizable start and stop
codons, and we did not detect ALKAL2 expression in stage HH10
embryos by in situ hybridization (data not shown). Taken together,
these observations suggest that other secreted molecules may be
responsible for activating LTK at the stages examined.
To test this possibility, we used in situ hybridization to examine
the expression of candidate ligands other than ALKAL1/2.
Accordingly, heparin-binding cytokine midkine has been
proposed as a ligand for ALK and functional studies in the chick
embryo suggest that it activates ALK to regulate proliferation of
sympathetic ganglia progenitors (Reiff et al., 2011). Therefore, we
analyzed the expression of midkine transcripts during neural crest
development. The results showed that midkinewas highly expressed
in the non-neural ectoderm of HH10 and HH20 embryos,
immediately juxtaposed to migrating neural crest cells positive for
HNK-1 (Fig. 5A-D). To characterize the localization of midkine
Fig. 3. LTK is not required for maintenance of neural crest identity. (A-C) Immunostaining of HH8 embryos after MO-mediated unilateral depletion of LTK
(A) showing no obvious difference in levels of Pax7 (B) or cleaved caspase 3 (C) (6 out of 6 embryos). (D-F) In situ hybridization of HH10 embryos after MO-mediated
unilateral depletion of LTK showing reduction in the average distance migrated on the right side but no obvious difference in expression levels of FoxD3 (5 out
of 6 embryos) (D),Ets1 (4 out of 6 embryos) (E) andSox10 (9 out of 11 embryos) (F). (G,H) Immunostaining after CRISPR/Cas9-mediated unilateral depletion of LTK
showing no obvious difference in Snail2 (G) and Sox9 (H) expression levels. (I) Quantification of the migratory neural crest area ratios between experimental and
contralateral controls showing significant decrease in the average distance migrated by LTK-depleted neural crest, on average to 89.7% for Snail2 (n=12, P=0.005)
and 80.3% for Sox9 (n=11, P=0.003). The data are normalized to the left side average of each group and a two-tailed paired t-test was used to calculate statistical
significance of the difference between left and right sides. Mean±s.e.m. values are plotted as black bars. (J) Immunostaining after CRISPR/Cas9-mediated unilateral
depletion of LTK showing reduction in HNK-1+ late migratory neural crest cells at the right side (23 out of 25 embryos). Scale bars: 50 µm.
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protein, we validated a commercial antibody with western blotting
(Fig. S7E). Subsequent immunostaining of embryos revealed the
presence of midkine in the basal lamina of the non-neural ectoderm
(Fig. 5E,F), as expected based on transcript expression.
Additionally, midkine protein was detected in the basal lamina of
the neuroepithelium (Fig. 5F), likely remaining from earlier
expression at the neural plate prior and during neurulation
(Fig. S7A-D) similar to mdk2 (mdkb) in zebrafish (Winkler and
Moon, 2001; Winkler et al., 2003). Interestingly, we observed
midkine signal around Pax7+ and HNK-1+ cells (Fig. 5G,H),
suggesting that midkine signals secreted by the surface ectoderm
into the extracellular matrix juxtaposing neural crest cells may be
received by the latter. This is consistent with an interaction with
membrane receptors of neural crest cells.
Loss of midkine impairs neural crest migration
If midkine is indeed a ligand for LTK, reducing its levels should
phenocopy LTK loss of function and cause increased cell death. To
test this, we inhibited production of midkine using a protein-based
CRISPR/Cas9 electroporation strategy (Hutchins and Bronner,
2018), in order to circumvent early expression at the neural plate.
To this end, we electroporated purified Cas9 protein and an in vitro
synthesized gRNA targeting the first exon of midkine (MK.1)
into the right side of the embryonic ectoderm after neural crest
specification but before neurulation, whereas a control gRNA was
electroporated into the left side. Embryos were allowed to develop
until stage HH9+ (Fig. 6A,F), then fixed and immunostained for
midkine, Pax7, HNK-1, Snail2, Ecad, Cad6B and cleaved caspase
3. This intervention resulted in a significant loss of midkine protein,
validating activity of MK.1 (Fig. S7F-H). Depletion of midkine
produced defects similar to LTK knockdown in the migratory
population, as seen by Snail2, Pax7 and HNK-1 immunostaining
(Fig. 6B,G,H), with an average reduction of the area occupied by
Snail2+ and Pax7+ cells to 71.5% and 75.4%% of controls,
respectively (Fig. 6K). Staining for cleaved caspase 3 revealed a
dramatic increase in the numbers of apoptotic cells (Fig. 6I,L) amongst
the migratory population (Fig. 6J), supporting a survival function for
midkine. No obvious EMT defects were seen by analyzing expression
of Ecad and Cad6B (Fig. 6C-E). These results showed that midkine
prevents apoptosis of neural crest cells in a similar manner to LTK,
consistent with a biologically relevant interaction.
Secreted midkine is internalized and promotes survival of
neural crest cells
It has been reported that, upon binding to receptor, midkine is
internalized by cells, a common phenomenon in RTK signaling
(Marmor and Yarden, 2004). Thus, if midkine produced by the
surface ectoderm binds to LTK in the migratory neural crest, one
might expect to find secreted molecules inside the latter cell
population. To investigate this possibility, we electroporated the
non-neural ectoderm of stage HH9 embryos with pCI-H2B-
RFP(midkine-FLAG) to express a CAG-driven carboxy-terminal
FLAG-tagged form of midkine (Fig. 7A). Interestingly, 10 h post-
electroporation, we observed FLAG signal within many Sox9+
migrating neural crest cells, despite the fact that the electroporation
was confined to the non-neural ectoderm (Fig. 7B-D). The results
suggest that midkine was secreted by the surface ectoderm and
internalized by migrating neural crest cells.
Fig. 4. LTK is required for neural crest survival. (A-D) Transverse sections of HH10 embryos immunostained for Snail2 (B) or Sox9 (D) after unilateral
CRISPR/Cas9-mediated depletion of LTK showing reduced number of migrating neural crest cells at the right side. RFP reporter and Cas9were electroporated on
both sides (A,C). (E) Quantification of Sox9+ cell count ratios between experimental and contralateral controls obtained from transverse sections showing
reduction of the number of cells in LTK-depleted neural crest populations on average to 65.3% (n=5, P=0.0006). The mean cell count per section for each
embryo side is plotted and a two-tailed paired t-test was used to calculate statistical significance of the difference between left and right sides. Mean±s.e.m.
values are plotted as black bars. (F-I) Immunostaining for cleaved caspase 3 after unilateral CRISPR/Cas9-mediated depletion of LTK showing increased number
of apoptotic cells (H) amongst the Pax7+ population (G,I). RFP reporter and Cas9 were electroporated on both sides (F). (J) Profile of normalized mean
fluorescence intensities acquired from dorsal view images (n=30) at equidistant positions from the midline showing increased levels of cleaved caspase 3 in the
LTK-depleted side. Mean±s.e.m. values are plotted as dashed lines. Scale bars: 50 µm.
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To confirm that the staining detected originated from secreted
midkine, we repeated this experiment using pCI-H2B-
RFP(midkine-ΔSP-FLAG), which drives expression of midkine-
FLAG lacking the signal peptide, encompassing the first amino-
terminal 25 amino acids (midkine-ΔSP) and thought to be important
for secretion. As expected, midkine-ΔSP remained inside
transfected cells in the surface ectoderm and was not observed
around or inside neural crest cells as was the case for full-length
midkine (Fig. 7E-H), confirming the importance of the signal
peptide for secretion. These results demonstrate that midkine
secreted by the non-neural ectoderm is taken up and internalized by
neural crest cells.
Midkine interacts with LTK
To test whether midkine and LTK interact in vivo, we performed a
proximity ligation assay (PLA). This method allows specific
protein-protein interactions to be detected in situ by secondary
antibodies conjugated to unique short DNA strands that hybridize to
allow a polymerase reaction that produces fluorescent signal when
targets are within ∼40 nM of distance (Söderberg et al., 2006). To
this end, we constructed pCAG(V5-LTK) and pCAG(V5-LTK-
isoform2), encoding CAG-driven V5-tagged constructs of both
LTK isoforms at the amino terminus of the mature protein, after
signal peptide cleavage. Next, we used ex ovo electroporation to
overexpress V5-LTK on the right side of stage HH5 embryos,
whereas pCI-H2B-RFP was electroporated on both sides to allow
use of cells on the left side as internal controls. For PLA,
the embryos were fixed at stage HH9/10 and processed for
cryosectioning. Immunostaining for V5 and midkine in adjacent
transverse sections confirmed presence of both target proteins in the
material used for PLA, and validated LTK localization at the cell
membrane (Fig. 8A,B,G). In sections subjected to PLA with the
same primary antibodies against V5 and midkine, we identified
fluorescent puncta indicative of interaction events specifically
around cells transfected with the canonical LTK isoform on the right
side, whereas only occasionally puncta were observed on cells on
the control side (Fig. 8C,D). Quantification of puncta across several
sections confirmed a significant enrichment of interaction events in
V5-LTK+ side of the sections analyzed (Fig. 8E). These results
strongly indicate that midkine binds to LTK and are consistent with
a receptor-ligand interaction. Furthermore, the signal yielded by
LTK isoform 2 (Fig. 8H,I), lacking most of the GlyR domain,
indicates that this region is not required for interaction with midkine
as it is for interaction with ALKAL1/2 (Reshetnyak et al., 2015). To
confirm these results with an alternative approach, we transfected
NIH/3T3 mouse fibroblasts with pCI-GFP(midkine-FLAG) and
pCI-H2B-RFP(V5-LTK) to perform co-immunoprecipitation
experiments. We detected both proteins in precipitates obtained
after incubation with an anti-FLAG antibody, demonstrating that
LTK and midkine bind to each other (Fig. 8F). Interestingly, only
the uppermost band seemed to have been co-immunoprecipitatied
with midkine, suggesting specific association with post-
translationally modified LTK, which would be expected if
midkine is a ligand.
If midkine does bind to LTK extracellularly, one would expect
high affinity even in the absence of the intracellular domain. In fact,
PLA performed with V5-LTK-ΔICD produced robust signal for
interaction events (Fig. 8J-L). An amino-terminal V5-tagged
construct lacking the extracellular domain (V5-LTK-ΔECD) also
produces some signal after PLA, albeit at much reduced levels
despite the similar construct size, which should confer comparable
transfection efficiency (Fig. 8M-O). Altogether, these data strongly
suggest that midkine is a survival factor that interacts with the
extracellular region of the LTK receptor to promote cell survival.
DISCUSSION
During their migratory phase, neural crest cells move in tightly
coordinated streams, with the number of cells and levels of
proliferation in each influencing the contribution and ultimately the
size of derived structures. Given that cell proliferation during
migration is limited (Kulesa et al., 2010), neural crest cells must rely
on mechanisms that ensure survival before and after colonization of
their target sites. Here, we describe a novel mechanism that
promotes survival of migrating cranial neural crest cells in the
chick embryo.
It has been proposed that, upon EMT and detachment from the
extracellular matrix, cells are exposed to different environments and
have to adapt to ensure survival during migration (Frisch and
Francis, 1994). Multiple lines of evidence suggest that biochemical
signals are required to protect migrating neural crest cells from
apoptosis. For example, neural tube cells forced to delaminate after
RhoB or Ets1 overexpression undergo apoptosis, and Sox9-driven
delamination rescues survival after RhoB overexpression, indicating
that Sox9 is required for survival (Cheung et al., 2005). HoxB5 is
likely to function upstream of Sox9, as perturbation of its signaling
resulted in Sox9 downregulation and increased apoptosis (Kam
et al., 2014). Similarly, inhibition of α4β1 integrin receptor causes
cell death of neural crest cells in vitro (Testaz and Duband, 2001),
Fig. 5. Midkine is expressed in the non-neural ectoderm and accumulates
in the basal lamina. (A-D) Transverse sections of the head of HH10 (A,B)
or trunk of HH20 (C,D) embryos obtained after in situ hybridization combined
with immunostaining showing expression of midkine transcripts in the non-
neural ectoderm (A,C) that overlies migrating neural crest cells (arrowheads)
stained for HNK-1 (B,D). (E) Immunostaining for midkine and HNK-1 in the
head region of an HH10 embryo. (F-H) Transverse section of the embryo in
E at the level of the dashed line showing protein accumulation in the basal
lamina (F) and around Pax7+ (G) and HNK-1+ (H) neural crest cells. NT, neural
tube. Scale bars: 50 µm.
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and antibody-mediated inhibition of sonic hedgehog ligands or
conditional knockout of smoothened result in death of neural crest
cells that colonize the branchial arches (Ahlgren and Bronner-
Fraser, 1999; Jeong et al., 2004). In zebrafish, tfap2a is required for
survival of preotic and postotic neural crest cells that migrate to
the pharyngeal region (Barrallo-Gimeno et al., 2004). Moreover,
anti-apoptotic roles of neural crest transcription factors are crucial
for survival in premigratory stages: for example, antisense
morpholino-mediated depletion of Sox10 or Id3 in Xenopus
embryos results in increased apoptosis of neural crest progenitor
cells (Honoré et al., 2003; Light et al., 2005; Kee and Bronner-
Fraser, 2005) and Snail factors act in both neural crest and cancer
cells in part by conferring resistance to apoptosis (Tríbulo et al.,
2004; Nieto, 2002; Vega et al., 2004).
Our data suggest that the interaction between midkine and LTK is
also crucial for proper neural crest survival during migration,
as reduced levels of either receptor or ligand result in migration
defects and cell death. This is consistent with previous in vitro data
suggesting migration and survival activities for both midkine and
LTK in cell lines (Kadomatsu and Muramatsu, 2004; Roll and
Reuther, 2012; Qi et al., 2000; Tong et al., 2007; Ueno et al., 1996,
1997; Yao et al., 2010; Zou et al., 2006). Recently, the activating
mutation on human ALK residue 1174 (ALK-F1174L), frequent
in neuroblastoma, was shown to have a strong survival effect on
cultured sympathetic neuroblasts, suggesting that a survival
function could help explain the bad prognosis associated with
excessive ALK signaling (Kramer et al., 2016). Although in
zebrafish LTK seems to be required only in the neural crest derived
Fig. 6. Midkine is required for neural crest survival, but not maintenance of specification. (A-J) Immunostaining of HH10 embryos following unilateral
loss of midkine mediated by CRISPR/Cas9 targeted by midkine (MK) gRNA (A,F) showing impaired migration with no loss of Snail2 (B,E) or Pax7 (G,J)
expression, reduction in HNK-1+ latemigratory population (8 out of 8 embryos) (H) and increased levels of cleaved caspase 3 levels (I,J), with no obvious effects in
the expression of Ecad (7 out of 7 embryos) (C) or Cad6B (7 out of 7 embryos) (D,E). (K) Quantification of the migratory neural crest area ratios between
experimental and contralateral controls showing significant decrease in the average distance migrated in the midkine-depleted side, on average to 71.5% for
Snail2 (n=6, P=0.008) and 75.4% for Pax7 (n=7, P=0.007). The data are normalized to the left side average of each group and a two-tailed paired t-test was used
to calculate statistical significance of the difference between left and right sides. Mean±s.e.m. values are plotted as black bars. (L) Profile of normalized mean
fluorescence intensities acquired from dorsal view images (n=6) at equidistant positions from the midline showing increased levels of cleaved caspase 3 in the
midkine-depleted side. Mean±s.e.m. values are plotted as dashed lines. Scale bars: 50 µm.
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population of iridophores, and is also important for their survival
(Fadeev et al., 2016), our data indicates that LTK has a broader
requirement in the neural crest of avian species. Studies in other
species will help understand the conservation of LTK requirement
in the neural crest.
Recently, ligands for the ALK/LTK GlyR domain have been
identified (Fadeev et al., 2018; Guan et al., 2015; Mo et al., 2017;
Reshetnyak et al., 2015; Zhang et al., 2014). Although the GlyR
domain seems to be only major recognizable extracellular domain
in LTK that is conserved in mammals, all ALK proteins and
non-mammalian LTK possess a conserved NMLM region as
well, composed of an LDLa and one or two MAM domains
(Lopes et al., 2008; Roll and Reuther, 2012). Proteins that bind these
extracellular domains, however, remain unknown. The ligand for
the LTK/ALK ortholog in Drosophila is the LDLa domain-
containing ligand jelly belly ( jeb), but an obvious ortholog is
absent from vertebrate genomes (Lee et al., 2003; Weiss et al.,
2001). After the first reports implicating midkine/pleiotrophin as
ligands for ALK (Stoica et al., 2001, 2002), different groups failed
to replicate activation of ALK by either putative ligand, placing the
existence of these interactions in question (Dirks et al., 2002;
Hugosson et al., 2014; Mathivet et al., 2007; Miyake et al., 2002;
Moog-Lutz et al., 2005; Motegi et al., 2004; Mourali et al., 2006;
Müller-Tidow et al., 2005). In contrast, our data are consistent with a
ligand-receptor interaction. First, absence of significant ALKAL
expression during early chicken development suggests that LTK
signaling in early migrating neural crest cells depends on a distinct
ligand. Second, using highly specific assays for detection of
protein-protein interactions, we present the first evidence that LTK
physically interacts with midkine in vivo and co-immunoprecipitates
with midkine in vitro. Finally, similarity of LTK and midkine loss-of-
function phenotypes and internalization of midkine by neural crest
cells strongly support a ligand-receptor relationship. Our data also
suggests that LTK is later downregulated in trunk neural crest cells as
they differentiate into sympathoadrenal precursors, at which time
they upregulate ALK, which is then required for midkine activity
(Hurley et al., 2006; Reiff et al., 2011). In a different situation,
midkine has been shown to confer resistance to cannabinoid anti-
tumoral activity in glioma cells and block autophagy-mediated cell
death specifically through activation of ALK, but not via other
receptors previously described, such as LRP1 and PTPRZ (Lorente
et al., 2011a,b). Altogether, these data strongly support a direct
ligand-receptor interaction between ALK/LTK and midkine.
However, given the resolution limit of PLA (∼40 nM) signal
production when using the secondary antibodies approach, our
results could also be explained by interaction within a multiprotein
complex. Consistent with this possibility, ALK becomes auto-
phosphorylated upon binding of midkine dimers to an integrin/LRP
complex (Muramatsu, 2010). The requirement of additional binding
partners to mediate interaction between midkine and ALK/LTK
may help explain the conflicting results in the literature.
Consistently associated with ALK and LTK activation, the
ERK/MAPK signaling pathway is a likely intracellular effector of
LTK survival activity (Fadeev et al., 2018; Roll and Reuther, 2012).
Our data suggest that expression of Snail2 or Sox9 (Cheung et al.,
2005; Tríbulo et al., 2004), neural crest transcription factors known to
promote neural crest survival, is not dependent on LTK, indicating the
existence of different transcriptional effectors of LTK function.
Fig. 7. Secreted midkine is internalized by migrating neural crest cells. (A) Diagram showing in ovo electroporation (EP) of the surface ectoderm from
a transverse section view. Downwards transfection is restricted to the non-neural ectoderm cell layer (NNE) and does not reach the neural crest (NC) underneath.
(B-D) Immunostaining of a transverse section through the embryonic head 10 h post-electroporation of midkine-FLAG showing RFP transfection confined to
the non-neural ectoderm (B) and secreted midkine-FLAG speckles in the underlying mesenchyme (white arrowheads) (C), including the vicinity of non-
transfected neural crest cells nuclei marked by Sox9 (yellow arrowheads), suggestive of internalization (D). (E-H) Immunostaining of a transverse section
showing comparison of FLAG-tagged full-length midkine speckles secreted into the mesenchyme by the transfected ectoderm (5 out of 5 embryos) (F) versus
a FLAG-tagged construct lacking the signal peptide (midkine-ΔSP) that remained inside the transfected cells (3 out of 3 embryos) (H). Exposure levels were
kept constant in both samples for purposes of comparison and in high levels to best reveal themesenchymemidkine-FLAG signal. NT, neural tube. Scale bars:
20 µm.
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Although we have not investigated which factors mediate LTK
survival activity intracellularly, other candidates are the pro-apoptotic
factors BMF and BIM, found to be downregulated by constitutively
active ALK-F1174L (Kramer et al., 2016). Further characterization of
the pathways downstream of LTK will be key for understanding the
full mechanism of LTK action in migrating neural crest cells.
Cumulatively, our results show that neural crest cells start
expressing the LTK receptor immediately prior to delamination and
subsequently encounter a midkine-rich intercellular environment at
early stages of migration.We show that midkine binds to LTK and is
internalized by LTK-expressing neural crest cells. In the absence
of either receptor or ligand, neural crest cells undergo apoptosis.
Thus, we propose that secreted midkine binds to the extracellular
region of LTK present in the membrane of neural crest cells to
trigger intracellular transduction pathways that promote survival and
migration, potentially as an activating ligand. We further speculate
Fig. 8. Midkine andLTKbind extracellularly. (A,B) Immunostaining of a transverse section after unilateral ectopic expression of V5-LTK showing efficacyof anti-V5
and anti-midkine antibodies used for PLA and membrane localization of V5-LTK. (C,D) PLA performed in adjacent sections of the same embryo shown in A,B
produces puncta (arrowheads) indicative of protein-protein interaction events (D) predominantly around the right-side RFP+ cells (C). (E) Quantification of PLA
puncta across several sections of two embryos showing enrichment on average to 7.2-fold (n=14, P<0.0001) at the V5-LTK side. The data for each section are
plotted and a two-tailed paired t-test was used to calculate statistical significance of the difference between left and right sides. Mean±s.e.m. values are plotted
as black bars. (F) Western blotting after anti-FLAG co-immunoprecipitation of lysates from mouse NIH/3T3 cells transfected with V5-LTK and an empty vector
(pCI-GFP) or midkine-FLAG showing presence of V5-LTK only in the midkine-FLAG sample. (G-O) PLA experiments after unilateral ectopic expression verified with
immunostaining (G,J,M) also produce positive signal for LTK isoform 2 (3 out of 3 embryos) (H,I), LTK-ΔECD (3 out of 3 embryos) (K,L) and LTK-ΔICD (3 out of
3 embryos) (N,O), with the latter exhibiting dramatically higher levels. RFP transfection reporter was electroporated on both sides (A,C,G,I,J,L,M,O). Gamma
adjustments were performed in order to improve visualization of medium intensity levels of RFP and V5 staining (A-C,G,I,J,L,M,O). Scale bars: 20 µm.
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that interactions between midkine and LTK function to maintain the
proper number of neural crest cells within a migratory stream. This
is consistent with findings in chick embryos where implanting
additional neural crest cells leads to regulation of cell number, such
that neural crest derivatives maintain their normal size (Baker et al.,
1997). This results in matching of cell numbers to the size of
derivatives via signaling events emanating from the environment.
Taken together, our data provide a framework for understanding
how midkine stimulates ALK-type receptors to trigger downstream
pathways involved in cell survival.
MATERIALS AND METHODS
Embryos and electroporation
Fertilized Gallus gallus eggs were obtained from McIntyre Poultry &
Eggs (Lakeside, CA, USA) and AA Lab Eggs (Westminster, CA, USA).
The eggs were incubated at 37°C and embryos at the desired stage were
collected as described (Chapman et al., 2001) and staged according to
Hamburger and Hamilton (1951). Gastrula-stage HH4 to HH6 embryos
were electroporated ex ovo (Sauka-Spengler and Barembaum, 2008) with
five 50-ms pulses of 5.2-5.4 V spaced by 100-ms intervals and cultured
until reaching HH8 to HH10 at 37°C. For electroporation of the non-neural
ectoderm, HH9 (8 somites) embryos were electroporated in ovo (Itasaki
et al., 1999) with five 50-ms pulses of 18 V spaced by 100-ms intervals
and re-incubated for 10 h at 37°C. Embryos efficiently electroporated,
based on FITC or RFP signal, were selected for downstream analysis.
Morpholino treatments
FITC-tagged standard control morpholino or splice-blocking morpholino
targeted to LTK exon8/intron8 junction (LTK-MO: CAGAGGGAGAT-
ACCTGGTAATCTTC) were electroporated at 0.5 mM. Injection solutions
were complemented with 1 µg/µl carrier DNA (empty pTK-EGFP;
Uchikawa et al., 2003). For activity validation, RNA samples isolated
from neural folds of embryos electroporated with LTK-MO (n=2) or
ctrl-MO (n=2) were reverse-transcribed with Superscript IV (Thermo Fisher
Scientific) and subjected to RT-PCR with the primers LTK-F1/LTK-R1
(Table S1). The PCR products were cloned into pGEM-T (Promega)
and sequenced.
CRISPR/CAS9-induced mutagenesis
Plasmids pCAG(Cas9) and cU6.3 driving expression of standard control
(Gandhi et al., 2017) or targeted gRNAs were electroporated into HH4-5
embryos. A template for a gRNA targeting LTK exon 20 (LTK.20:
GCAGAGAGATGTTCTTCCGT) was cloned into a BsaI-digested cU6.3
backbone vector after annealing single-strand oligos to form compatible
double-strand DNA. For LTK.20 validation, immortalized DF-1 chicken
embryonic fibroblast cells (ATCC, CRL-12203, RRID:CVCL_0570)
constitutively expressing Cas9 (Gandhi et al., 2017) were cultured in
DMEM (Corning) supplemented with 10% fetal bovine serum (Gibco)
and 1% penicillin/streptomycin (Corning) at 37°C and 5% CO2 in 12-well
plates to 80% confluency. For transfection, each well received 2 µl of
Lipofectamine 3000 reagent and 2 µl P3000 reagent (Thermo Fisher
Scientific) with 1 µg of cU6.3(LTK.20). Transfected cells were cultured for
48 h, trypsinized and genomic DNAwas harvested with the DNeasy Blood
and Tissue kit (QIAGEN). A 1.2 kb region around the LTK.20 target was
PCR-amplified with the primers LTK-F2/LTK-R2 and the product was
ligated into pGEM-T (Promega) for Sanger sequencing genotyping
of 12 individual clones. For midkine, a gRNA targeted to exon 1
(MK.1: GAGGCTGCCAAAGCCAAGAA) was synthesized in vitro,
together with a standard control gRNA (Talbot and Amacher, 2014).
EnGen Cas9 protein (New England Biolabs) was complexed with equimolar
quantities of purified gRNA for 15 min at 37°C and diluted to 0.5 µg/µl for
electroporation into HH5-6 embryos (Hutchins and Bronner, 2018).
Plasmid constructs
To create pCAG(V5-LTK), pCAG(V5-LTK-isoform2), pCAG(V5-LTK-
ΔICD) and pCAG(V5-LTK-ΔECD), the signal peptide and the remaining
full-length or truncated sequences of LTK were PCR amplified from
stage HH 10 cDNA with the primer pairs pCAG-LTK-F/V5-LTK-R and
V5-LTK-F/pCAG-LTK-R (full-length) or V5-LTK-F/pCAG-LTK-R2
(-ΔICD), or pCAG-LTK-F/V5-LTK-R2 and V5-LTK-F2/pCAG-LTK-R
(-ΔECD) (Table S1), and ligated using Gibson Assembly (NEB) into the
backbone of pCI-H2B-RFP (Betancur et al., 2010) digested with EcoRI
and NotI (to remove IRES and H2B-RFP). To create pCI-H2B-RFP(V5-
LTK-ΔICD), the coding sequence for the carboxyl terminus up to residue
R880 was amplified with the primer pair V5-LTK-F/pCI-LTK-R2 (Table S1)
and Gibson assembled with the signal peptide sequence into pCI-H2B-RFP
digested with EcoRV. To create pCI-H2B-RFP(midkine-FLAG), pCI-H2B-
RFP(midkine-ΔSP-FLAG) and pCI-GFP(midkine-FLAG), full-length or
truncated midkine sequences lacking a stop codon were PCR-amplified
with the primers pCI-MK-F/MK-R or pCI-MK-F2/MK-R, and Gibson
assembled with the single-strand oligos FLAG-MK-R and FLAG-pCI-F
(Table S1) into pCI-H2B-RFP or pCI-GFP (Megason and McMahon, 2002)
digestedwithClaI and SmaI. Sanger sequencingwas used to confirm integrity
of clones used for transfection.
Pharmacological inhibitor treatments
The right-side head mesenchyme of stage HH9 embryos was injected in ovo
with Ringer’s solution containing 100 µM ceritinib (Selleck Chemicals,
S7083) or 100 µM crizotinib (Sigma-Aldrich, PZ0191) ALK inhibitors,
prepared from 10 mM stocks diluted in DMSO; Ringer’s solution with 1%
DMSOwas injected into the left-side mesenchyme as a contralateral control.
The eggs were closed and re-incubated for 5 h at 37°C.
Culture of cranial neural fold explants
Stage HH5 embryos were electroporated ex ovo with control gRNA on the
left side and LTK.20 gRNA on the right side and cultured to 5-6 somites.
The neural folds were dissected in Ringer’s solution and transferred into
wells of fibronectin-coated glass chamber slides (LabTek) containing 200 µl
of 10% horse serum/15% embryo in Modified Eagle’s Medium (Bronner-
Fraser and García-Castro, 2008). After 1 h, 200 µl the same medium were
added and the explants were cultured for 24 h at 37°C and 5% CO2. The
cultured explants were fixed in 4% paraformaldehyde (PFA) for 20 min and
processed for immunostaining, followed by mounting in Fluoromount
(Southern Biotech) and imaging with an Axiocam 506 mono camera and an
Apotome.2 microscope (Zeiss).
In situ hybridization
Stage HH4 to HH20 embryos were fixed overnight in 4%PFA in PBS at 4°C.
Fixed embryos were washed and dissected in dyethil pyrocarbonate-treated
PBS+0.1% Tween-20 (PBST), dehydrated in a methanol/PBS series and
stored in methanol at −20°C. Rehydrated embryos were hybridized as
whole-mount embryos at 68-70°C (Wilkinson, 1992; Simões-Costa et al.,
2015). Colorimetric signal was developed with NBT-BCIP substrates
(Roche), followed by fixing in 4% PFA in PBS and serial dehydration and
rehydration in methanol before imaging. Templates for LTK (Simões-Costa
et al., 2014) and Sox10 (Betancur et al., 2010) probes were described
previously. A template for midkine probe was PCR-amplified with the
primers MK-F1 and MK-R1 (Table S1) and cloned into pGEM-T vector
(Promega). Template DNAwas linearized using unique restriction sites 5′ to
the insert, purified and transcribed with digoxigenin-labeled nucleotides
(Roche). Synthesized probes were purified using Illustra ProbeQuant G-50
Micro Columns (GE Healthcare).
Immunohistochemistry
Stage HH8 to HH10 embryos were fixed for 15-20 min in 4% PFA in 0.1 M
phosphate buffer, pH 7.4, at room temperature. Fluorescent immunostaining
was performed in whole mounts as described (Ezin et al., 2009). The
embryos were permeabilized with 0.5% Triton X-100 in PBS (PBT).
Blocking was performed with 10% goat or donkey serum in PBT for 1-3 h
and antibodies were diluted in the same blocking solution. Primary
antibodies used were: mouse IgM anti-HNK-1 (DSHB, 3H5, RRID:
AB_2314644; 1:5), goat IgG anti-fluorescein (Novus, NB600-493, RRID:
AB_10001854; 1:500), mouse IgG1 anti-Pax7 (DSHB, pax7, RRID:
AB_528428; 1:5), rabbit IgG anti-cleaved caspase 3 (R&D Systems,
AF835, RRID:AB_2243952; 1:500), rabbit IgG anti-Sox9 (Millipore,
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AB5535, RRID:AB_2239761, 1:500), rabbit IgG anti-midkine (Abcam,
ab52637, RRID:AB_880698, 1:500), mouse IgG2a anti-V5 (Thermo Fisher
Scientific, R960-25, RRID:AB_2556564, 1:500), mouse IgG2a anti-Ecad
(BD Biosciences, 610181, RRID:AB_397580, 1:1000), mouse IgG1 anti-
FLAG M2 (Sigma-Aldrich, F1804, RRID:AB_262044, 1:500). Secondary
antibodies used were: goat anti-mouse IgM Alexa 488/568, goat anti-mouse
IgG1 488/647, goat anti-mouse IgG2a 350/488, goat anti-rabbit IgG Alexa
488/647 (Molecular Probes; 1:500 for Alexa 350/647 and 1:100 for Alexa
488/568). Images were captured with an Axiocam 506 mono camera and an
Apotome.2 microscope (Zeiss), and Zen Blue software (Zeiss) was used to
create maximum intensity projections and perform gamma adjustments.
Histology
Embryos were cryoprotected by incubation for several hours in PBS
containing 5% then 15% sucrose, at 4°C. Protected embryoswere equilibrated
in 7.5% gelatin/15% sucrose in 0.5× PBS at 37°C for 3-8 h and mounted at
room temperature. The blocks were snap-frozen in liquid nitrogen and stored
at −80°C. Sections of 12-14 µm (immunofluorescence) or 20-25 µm (in situ
hybridization) were obtained using a Microm HM550 cryostat (Thermo
Fisher Scientific) and collected on Super Frost Plus slides (Thermo Fisher
Scientific), let dry for at least 10 min and mounted in Fluoromount (Southern
Biotech) after gelatin removal in a 37°C bath for 15-20 min.
Proximity ligation assay (PLA)
Stage HH5 embryos were co-electroporated ex ovo with 2.5 µg/µl
pCAG(V5-LTK), pCAG(V5-LTK-isoform2), pCAG(V5-LTK-ΔECD) or
pCAG(V5-LTK-ΔICD) and/or 1 µg/µl pCI-H2B-RFP reporter, cultured to
stage HH10 and fixed for 20 min in 4% PFA in 0.1 M PB before embedding
and sectioning. The area containing 12-14 sections on SuperFrost slides was
delimited with a hydrophobic pen before gelatin removal. The sections were
permeabilized with 0.1% Triton X-100 in PBS and blocked with 10%
donkey serum in PBST. Primary antibody incubation was performed
overnight at 4°C with rabbit IgG anti-midkine (Abcam, ab52637, RRID:
AB_880698, 1:500) and mouse IgG2a anti-V5 (Thermo Fisher Scientific,
R960-25, RRID:AB_2556564, 1:500) diluted in blocking solution. Duolink
PLA probes (Sigma) were diluted in the same blocking solution and green
Duolink Fluorescent Detection Reagent (Sigma) was used to generate signal
according to the manufacturer’s instructions.
Quantification and statistical analysis
To quantify the neural crest area, dorsal view micrographs were used to
delimit and measure the Pax7+, Snail2+ or Sox9+ field of each side of a
HH9+ embryo head. To count Sox9+ cells, stained nuclei on each side of
14-18 transverse non-consecutive sections of five embryos were identified
and measured with the tool Analyze Particles in Fiji (Schindelin et al.,
2012). PLA puncta in the dorsal region in 14 sections of two embryos were
manually counted. Statistical significance was determined with a two-tailed
paired t-test.
Immunoprecipitation
NIH/3T3 mouse embryonic fibroblasts (ATCC, CRL-1658, RRID:
CVCL_0594) in DMEM (Corning) supplemented with 10% fetal bovine
serum (Gibco) and 1% penicillin/streptomycin (Corning) were cultured at
37°C and 5% CO2 in 100 mm plates to 70% confluency. Transfection was
performed using Lipofectamine 3000 (Invitrogen). Each well received
30 µl of Lipofectamine 3000 reagent and 30 µl P3000 reagent with 10 µg
of pCAG(V5-LTK) and 7 µg of pCI-GFP(midkine-FLAG) or pCI-GFP.
Transfected cells were cultured for 24 h and lysed for 30 min in 1 ml of
150 mM NaCl/50 mM Tris pH 7.4/1% NP-40 buffer at 4°C. Lysates
were cleared by centrifugation (15 min at 20,000 g) at 4°C and pre-
incubation with protein-G agarose for 15 min at 4°C. 500 µl of pre-cleared
lysates were immunoprecipitated by protein-G agarose beads coated with
6 µg mouse IgG1 anti-FLAG M2 (Sigma-Aldrich, F1804, RRID:
AB_262044) for 8 h at 4°C.
Western blotting
Input (20-30 µg) and immunoprecipitated samples or 10 µg of protein from
HH10 embryos lysed in 8 M urea/2.5% SDS for 15 min at 65°Cwere loaded
and separated in a Bolt 4-12% Bis-Tris Plus gel (Thermo Fisher Scientific).
Transfer to nitrocellulose membrane was performed at 100 V for 1 h at 4°C
in 25 mM Tris/0.2 M glycine/20% methanol buffer. The membrane was
blocked with 5% bovine serum albumin and 0.1% Tween-20 in Tris-
buffered saline (TBST), pH 7.6 for 1 h and incubated with primary
antibodies rabbit mouse IgG2a anti-V5 (Thermo Fisher Scientific, R960-25,
RRID:AB_2556564, 1:2000) and mouse IgG1 anti-FLAG M2 (Sigma-
Aldrich, F1804, RRID:AB_262044, 1:500) or IgG anti-midkine (Abcam,
ab52637, RRID:AB_880698, 1:1000) diluted in blocking solution
overnight at 4°C. Secondary antibody incubation was performed with
goat peroxidase-labeled anti-mouse IgG (KPL, 74-1806; 1:10,000) or anti-
rabbit IgG (KPL, 74-1506; 1:25,000) in 5% milk in TBST for 1 h. Post-
primary and secondary antibody washes were performed in TBST. For
radiographic detection, chemiluminescence was developed with the ECL
Western Blotting System (GE Healthcare).
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Scarpa, E., Szabó, A., Bibonne, A., Theveneau, E., Parsons, M. and Mayor, R.
(2015). Cadherin switch during EMT in neural crest cells leads to contact inhibition
of locomotion via repolarization of forces. Dev. Cell 34, 421-434.
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch,
T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B. et al. (2012). Fiji: an
open-source platform for biological-image analysis. Nat. Methods 9, 676-682.
Schwarz, Q., Vieira, J. M., Howard, B., Eickholt, B. J. and Ruhrberg, C. (2008).
Neuropilin 1 and 2 control cranial gangliogenesis and axon guidance through
neural crest cells. Development 135, 1605-1613.
Simões-Costa, M., Tan-Cabugao, J., Antoshechkin, I., Sauka-Spengler, T. and
Bronner, M. E. (2014). Transcriptome analysis reveals novel players in the cranial
neural crest gene regulatory network. Genome Res. 24, 281-290.
Simões-Costa, M., Stone, M. and Bronner, M. E. (2015). Axud1 Integrates Wnt
Signaling and Transcriptional Inputs to Drive Neural Crest Formation. Dev. Cell
34, 544-554.
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Winkler, C., Schäfer, M., Duschl, J., Schartl, M. and Volff, J. N. (2003). Functional
divergence of two zebrafish midkine growth factors following fish-specific gene
duplication. Genome Res. 13, 1067-1081.
Yao, X., Tan, Z., Gu, B., Wu, R.-R., Liu, Y.-K., Dai, L.-C. and Zhang, M. (2010).
Promotion of self-renewal of embryonic stem cells by midkine. Acta Pharmacol.
Sin. 31, 629-637.
Zhang, H., Pao, L. I., Zhou, A., Brace, A. D., Halenbeck, R., Hsu, A. W.,
Bray, T. L., Hestir, K., Bosch, E., Lee, E. et al. (2014). Deorphanization of the
human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of
the extracellular proteome. Proc. Natl. Acad. Sci. USA 111, 15741-15745.
Zou, P., Muramatsu, H., Miyata, T. and Muramatsu, T. (2006). Midkine, a heparin-
binding growth factor, is expressed in neural precursor cells and promotes their
growth. J. Neurochem. 99, 1470-1479.
13
RESEARCH ARTICLE Development (2018) 145, dev164046. doi:10.1242/dev.164046
D
E
V
E
LO
P
M
E
N
T
